2nd Annual Palm Fruit Bioactives Workshop:
Advancing Market Potentials of Palm Bioactives Through Scientific Discoveries
Tuesday, October 119am – 3:30pm (breakfast/pre-reg 8:30am)
Ticket to Manufacturers Welcome Reception on Tuesday, October 11 from 5 to 6:30pm included with this workshop!
Highlights:
- Latest Clinical Trial and Research Updates
- Application Advantages
- Market Trends
From the oil palm fruits, three primary bioactives namely vitamin E palm tocotrienols, mixed palm carotenoids and palm phenolic phytonutrients are available. Research has brought to light novel and exciting health benefits of these bioactives deliverable in the form of nutraceutical and cosmeceutical concentrates, suitable for various product formulations. Components of palm can be used for natural color, shelf stable oils (no hydrogenation required), petroleum alternatives, antioxidants, and much, much more.
This workshop will highlight latest research and technical updates as well as market trends of these novel palm bioactives. Join us for this dynamic workshop to learn, share and exchange ideas on the trends and applications of these bioactives.
Breakfast, lunch, and workbooks included in registration feeRegistration Fee
$95
Agenda-at-a-Glance
8:30-9am
Registration
9-9:05am
Introduction
Market Trend
9:05–9:45am
Palm Bioactives: Examining Current Market Trend and Application Potentials
Presented by: Mr. Mike Danielson
KOCINA Marketing and Branding, USA
Tocotrienol Session
9:45–10:35am
Tocotrienol Against Stroke: From the Lab to Human Clinical Studies
Presented by: Plenary Paper Prof. Chandan K. Sen
OSUMC, Columbus, Ohio
10:35-10:55am
Session Break
10:55–11:35am
Palm Mixed Tocotrienols for Boomers – Antioxidant & Immune Function Support
Presented by: Dr. Dayong Wu
Tufts University
11:35am–12:15pm
"You Are What You Absorb" – Challenges in the Utilization of Palm Tocotrienol Complex as Nutraceutical Product
Presented by: Prof. Tony Kong
Rutgers
12:15-1:15pm
Lunch
Palm Oil / Carotenoid Session
1:15–1:55pm
Sustainability and Nutritional Facts about Red Palm Oil
Presented by: Mr. U R Unnithan
CAROTINO
1:55-2:35pm
Palm Mixed Carotenes and Disease Prevention
Presented by: Dr. Monica Orozco
Universidad del Valle de Guatemala
Polyphenols Session
2:35–3:15pm
Positive Outcomes of Oil Palm Phenolics on Degenerative Diseases
Presented by: Dr. Kalyana Sundram
MPOC
3:15-3:20pm
Closing
Speakers
Mike Danielson
Mike Danielson is Director of the Health and Medical Division for Media Relations, Inc., and has been a driving force behind this division since joining the agency in 1988. He has been directly involved with hundreds of highly successful consumer and business-to-business promotional campaigns involving strategic planning, market research, content development, performance-based execution of campaign programs and evaluation. He specializes in helping clients translate their big-picture goals into detailed and effective marketing programs; and has significant marketing and new product launch experience within the health and natural products industry as well as experience with brokering industry-related connections.
Mike Danielson is Director of the Health and Medical Division for Media Relations, Inc., and has been a driving force behind this division since joining the agency in 1988. He has been directly involved with hundreds of highly successful consumer and business-to-business promotional campaigns involving strategic planning, market research, content development, performance-based execution of campaign programs and evaluation. He specializes in helping clients translate their big-picture goals into detailed and effective marketing programs; and has significant marketing and new product launch experience within the health and natural products industry as well as experience with brokering industry-related connections.
Dr. Chandan Sen
Dr. Chandan Sen is a tenured Professor of Surgery and the Executive Director of the Ohio State University Comprehensive Wound Center. He is also the Associate Dean for Research at The Ohio State University Medical Center. At the pleasure of the Ohio State University, Dr. Sen serves as the Champion of Change for the National Institute of Health (NIH). He also serves on the national NIH panel on public-private partnership. Dr. Sen provides leadership to the Medical Center’s Technology Commercialization and Industry Partnership program. After completing his Masters of Science in Human Physiology from the University of Calcutta, Dr. Sen received his PhD in Physiology from the University of Kuopio in Finland. Dr. Sen trained as a postdoctoral fellow at the University of California at Berkeley’s Molecular and Cell Biology department. His first faculty appointment was in the Lawrence Berkeley National Laboratory in California. In fall of 2000, Dr. Sen moved to the Ohio State University where he established a program on tissue injury and repair. Currently, Dr. Sen is a Professor and Vice Chair of Research of Surgery. His research program is housed in the Davis Heart and Lung Research Institute where he serves as a Deputy Director and the Director of the Regenerative Medicine Program. Dr. Sen’s current research on tissue injury and repair is split into three programs: stroke, post-infarction myocardial remodeling and cutaneous wound healing. He is a PI of several projects including four clinical trials one of which has been recently funded by the MPOB and PEMANDU. He is the Director of the Novel Clinical and Translational Methodologies Program as well as of the Pilot Studies program of the Center for Clinical and Translational Sciences at Ohio State which was funded by the NIH for $34 million in 2008.
Dr. Sen is a widely recognized expert in redox and oxygen biology. He is the author of the most cited work in tocotrienol. He is the Editor-in-Chief of the #1 rated journal in redox biology Antioxidants & Redox Signaling (impact factor 8.209). He is also an Associate Editor of the prestigious American Physiological Society journal Physiology Genomics. He is the Editor-in-Chief of the Wound Healing Society’s yearbook Advances in Wound Care. Dr. Sen has published over 250 publications and is cited over 900 times a year in the literature.
Dr. Chandan Sen is a tenured Professor of Surgery and the Executive Director of the Ohio State University Comprehensive Wound Center. He is also the Associate Dean for Research at The Ohio State University Medical Center. At the pleasure of the Ohio State University, Dr. Sen serves as the Champion of Change for the National Institute of Health (NIH). He also serves on the national NIH panel on public-private partnership. Dr. Sen provides leadership to the Medical Center’s Technology Commercialization and Industry Partnership program. After completing his Masters of Science in Human Physiology from the University of Calcutta, Dr. Sen received his PhD in Physiology from the University of Kuopio in Finland. Dr. Sen trained as a postdoctoral fellow at the University of California at Berkeley’s Molecular and Cell Biology department. His first faculty appointment was in the Lawrence Berkeley National Laboratory in California. In fall of 2000, Dr. Sen moved to the Ohio State University where he established a program on tissue injury and repair. Currently, Dr. Sen is a Professor and Vice Chair of Research of Surgery. His research program is housed in the Davis Heart and Lung Research Institute where he serves as a Deputy Director and the Director of the Regenerative Medicine Program. Dr. Sen’s current research on tissue injury and repair is split into three programs: stroke, post-infarction myocardial remodeling and cutaneous wound healing. He is a PI of several projects including four clinical trials one of which has been recently funded by the MPOB and PEMANDU. He is the Director of the Novel Clinical and Translational Methodologies Program as well as of the Pilot Studies program of the Center for Clinical and Translational Sciences at Ohio State which was funded by the NIH for $34 million in 2008.
Dr. Sen is a widely recognized expert in redox and oxygen biology. He is the author of the most cited work in tocotrienol. He is the Editor-in-Chief of the #1 rated journal in redox biology Antioxidants & Redox Signaling (impact factor 8.209). He is also an Associate Editor of the prestigious American Physiological Society journal Physiology Genomics. He is the Editor-in-Chief of the Wound Healing Society’s yearbook Advances in Wound Care. Dr. Sen has published over 250 publications and is cited over 900 times a year in the literature.
Dayong Wu, MD, PhD
Dr. Dayong Wu is the Associate Director of the Nutritional Immunology Laboratory, Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University and Associate Professor at the Gerald J. and Dorothy R. Friedman School of Nutrition Science and Policy, Tufts University. His research areas include molecular mechanisms of age-related changes in immune cells, effects of dietary lipids, antioxidant nutrients, and functional food on immune and inflammatory responses. As one of his long pursued research subject, Dr. Wu’s has made significant contribution to our understanding of how vitamin E (tocopherols) improve immune functions. Recently, after publishing the first evidence suggesting tocotrienol’s immune-enhancing effect in an animal study, he has directed his interest to tocotrienols for their potential benefit in immune health. Dr. Wu is a member of the American Society for Nutrition and the American Ageing Association, and has authored numerous research publications and review articles. He has a degree in Medicine and a Ph.D. in Immunology from Jilin University, Bethune School of Medicine, China. He received his post-doctoral training at Tufts University.
Dr. Dayong Wu is the Associate Director of the Nutritional Immunology Laboratory, Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University and Associate Professor at the Gerald J. and Dorothy R. Friedman School of Nutrition Science and Policy, Tufts University. His research areas include molecular mechanisms of age-related changes in immune cells, effects of dietary lipids, antioxidant nutrients, and functional food on immune and inflammatory responses. As one of his long pursued research subject, Dr. Wu’s has made significant contribution to our understanding of how vitamin E (tocopherols) improve immune functions. Recently, after publishing the first evidence suggesting tocotrienol’s immune-enhancing effect in an animal study, he has directed his interest to tocotrienols for their potential benefit in immune health. Dr. Wu is a member of the American Society for Nutrition and the American Ageing Association, and has authored numerous research publications and review articles. He has a degree in Medicine and a Ph.D. in Immunology from Jilin University, Bethune School of Medicine, China. He received his post-doctoral training at Tufts University.
A.-N. Tony Kong, Ph.D.
Ah-Ng Tony Kong is Professor II (Distinguished), Glaxo Chair Professor of Pharmaceutics and Director of the Graduate Program in Pharmaceutical Science at Rutgers, The State University of New Jersey. He is the Co-Leader of the Carcinogenesis and Cancer Prevention program, Co-Director of the PK-PD Core of the Cancer Institute of New Jersey, the Associate Director for the Center for Cancer Prevention Research, and a member of the Environmental & Occupational Health Sciences Institute.
Dr. Kong received his B.S. in Pharmacy in 1983 from the University of Alberta, Canada and his Ph.D. in Pharmacokinetics and Pharmacodynamics in 1989 from the State University of New York at Buffalo. He received his post-doctoral training in molecular genetics and cellular signaling from 1989-1991 at the National Institutes of Health (NIH). He was on the faculty of Thomas Jefferson University Medical School and the University of Illinois at Chicago before joining Rutgers in early 2001. Dr. Kong continues to serve on the NIH Study Section since 1999 and he has been continued receiving funding support from the NIH since 1993. He has trained more than 30 post-doctoral fellows, visiting professors, Ph.D. and M.S. students. He has published more than 160 original research, review articles and book-chapters. He has chaired and given presentations in many National and International Symposia. His research integrates pharmacokinetics, cellular signaling, epigenetics, oxidative/redox/inflammatory stress response and Nrf2-mediated nuclear transactivation & signaling, and in vivo pharmacodynamics of dietary phytochemicals and drugs. He is an Editor of Pharmaceutical Research, North America Editor of Acta Pharmacologica Sinica and member of editorial advisory boards of Biopharmaceutics and Drug Disposition, Carcinogenesis, Molecular Carcinogenesis, and Cancer Prevention Research (AACR).
Ah-Ng Tony Kong is Professor II (Distinguished), Glaxo Chair Professor of Pharmaceutics and Director of the Graduate Program in Pharmaceutical Science at Rutgers, The State University of New Jersey. He is the Co-Leader of the Carcinogenesis and Cancer Prevention program, Co-Director of the PK-PD Core of the Cancer Institute of New Jersey, the Associate Director for the Center for Cancer Prevention Research, and a member of the Environmental & Occupational Health Sciences Institute.
Dr. Kong received his B.S. in Pharmacy in 1983 from the University of Alberta, Canada and his Ph.D. in Pharmacokinetics and Pharmacodynamics in 1989 from the State University of New York at Buffalo. He received his post-doctoral training in molecular genetics and cellular signaling from 1989-1991 at the National Institutes of Health (NIH). He was on the faculty of Thomas Jefferson University Medical School and the University of Illinois at Chicago before joining Rutgers in early 2001. Dr. Kong continues to serve on the NIH Study Section since 1999 and he has been continued receiving funding support from the NIH since 1993. He has trained more than 30 post-doctoral fellows, visiting professors, Ph.D. and M.S. students. He has published more than 160 original research, review articles and book-chapters. He has chaired and given presentations in many National and International Symposia. His research integrates pharmacokinetics, cellular signaling, epigenetics, oxidative/redox/inflammatory stress response and Nrf2-mediated nuclear transactivation & signaling, and in vivo pharmacodynamics of dietary phytochemicals and drugs. He is an Editor of Pharmaceutical Research, North America Editor of Acta Pharmacologica Sinica and member of editorial advisory boards of Biopharmaceutics and Drug Disposition, Carcinogenesis, Molecular Carcinogenesis, and Cancer Prevention Research (AACR).
U.R.Unnithan
U.R.Unnithan is a Master’s degree holder in Chemical Engineering from ICT (India’s Premier Chemical Technology Institute) and a Gold Medal Winner at the APEX MBA program from the National University of Singapore. Prior to joining CAROTINO Sdn Bhd in Malaysia, he worked with the Unilever Group in India at a Senior Management level. Currently he is the Executive Director of CAROTINO Sdn Bhd which is a member of the well established J.C.Chang Group of companies and is responsible for all Palm Oil downstream businesses of the group. He has been involved with the commercialization of the Red Palm Oil and Palm Neutraceuticals projects from the very concept, to evaluation of R&D, to scale up of the plant to a commercial scale and in its global marketing efforts. He is actively involved in R&D commercialization of Palm Oil downstream products and works closely with the Malaysian Palm Oil Board (MPOB) and other leading Research Institutes worldwide. He owns 3 International Patents in the field of Oils & Fats. He is a member of the Technical Promotion and Marketing Sub-committee of MPOB’s PAC (Program Action Committee). He is also a member of the Americas- Regional committee of MPOC. He has published and presented papers on these subjects in leading journals and at various scientific and marketing Conferences around the world. He is currently the Deputy President of The Malaysian Biodiesel Association. He has 27 years of experience in the Oils, Fats and Oleo-chemical industry and is also an Advanced Toastmaster.
U.R.Unnithan is a Master’s degree holder in Chemical Engineering from ICT (India’s Premier Chemical Technology Institute) and a Gold Medal Winner at the APEX MBA program from the National University of Singapore. Prior to joining CAROTINO Sdn Bhd in Malaysia, he worked with the Unilever Group in India at a Senior Management level. Currently he is the Executive Director of CAROTINO Sdn Bhd which is a member of the well established J.C.Chang Group of companies and is responsible for all Palm Oil downstream businesses of the group. He has been involved with the commercialization of the Red Palm Oil and Palm Neutraceuticals projects from the very concept, to evaluation of R&D, to scale up of the plant to a commercial scale and in its global marketing efforts. He is actively involved in R&D commercialization of Palm Oil downstream products and works closely with the Malaysian Palm Oil Board (MPOB) and other leading Research Institutes worldwide. He owns 3 International Patents in the field of Oils & Fats. He is a member of the Technical Promotion and Marketing Sub-committee of MPOB’s PAC (Program Action Committee). He is also a member of the Americas- Regional committee of MPOC. He has published and presented papers on these subjects in leading journals and at various scientific and marketing Conferences around the world. He is currently the Deputy President of The Malaysian Biodiesel Association. He has 27 years of experience in the Oils, Fats and Oleo-chemical industry and is also an Advanced Toastmaster.
Monica Orozco, Ph.D.
Monica Orozco, Ph.D., is the quality coordinator and associate researcher at the Plant Protection Lab Research Institute at Universidad del Valle de Guatemala where she also lectures on various courses in her field of expertise. She is also the post-doctoral fellow and project manager of plasma NTBI generation in men and women after the ingestion of ferrous sulfate supplements at the Center for the Study of Sensory Impairment, Aging and Metabolism. Dr. Orozco has a doctorate in food and nutritional sciences from the University of Manitoba, Winnipeg, a master’s in food science and technology, a liceniate in Biochemistry and a bachelor’s in scientis from the Universidad del Valle de Guaetemala. She is also a published author.
Monica Orozco, Ph.D., is the quality coordinator and associate researcher at the Plant Protection Lab Research Institute at Universidad del Valle de Guatemala where she also lectures on various courses in her field of expertise. She is also the post-doctoral fellow and project manager of plasma NTBI generation in men and women after the ingestion of ferrous sulfate supplements at the Center for the Study of Sensory Impairment, Aging and Metabolism. Dr. Orozco has a doctorate in food and nutritional sciences from the University of Manitoba, Winnipeg, a master’s in food science and technology, a liceniate in Biochemistry and a bachelor’s in scientis from the Universidad del Valle de Guaetemala. She is also a published author.
Kalyana Sundram, Ph.D., FASc, FNS
Kalyana Sundram, Ph.D., FASc, FNSM, is currently deputy CEO and director, science and environment, Malaysian Palm Oil Council (MPOC). He has 30 years of research experiences with various aspects of oils and fats process technologies, nutrition and technical marketing. He is a fellow of the Malaysian Academy of Sciences and member of several international professional associations.
Dr. Sundram is also an acknowledged expert on the health and nutrition of fats, fatty acids and their minor constituents. He has served on WHO, FAO and IUNS expert consultations, published extensively on palm oil and holds 12 patents. He has coordinated more than 165 research projects on palm oil and its components, contracted to international research centers by the Malaysian Palm Oil Board and is an active reviewer for a number of international journals with focus on edible oils and fats.
Dr. Sundram’s expertise has been built-up through a sound publication record and collaborative research programs with American, Australian and European research centers. His work has won prestigious local and international awards including that of the Stanford University San Jose Tech Museum Intel Environment Award, the Geneva Inventions and Innovations Gold Award and seen successful product commercialization in the United States that resulted in the NASDAQ listing of Smart Balance Inc. based on his patented invention.
Kalyana Sundram, Ph.D., FASc, FNSM, is currently deputy CEO and director, science and environment, Malaysian Palm Oil Council (MPOC). He has 30 years of research experiences with various aspects of oils and fats process technologies, nutrition and technical marketing. He is a fellow of the Malaysian Academy of Sciences and member of several international professional associations.
Dr. Sundram is also an acknowledged expert on the health and nutrition of fats, fatty acids and their minor constituents. He has served on WHO, FAO and IUNS expert consultations, published extensively on palm oil and holds 12 patents. He has coordinated more than 165 research projects on palm oil and its components, contracted to international research centers by the Malaysian Palm Oil Board and is an active reviewer for a number of international journals with focus on edible oils and fats.
Dr. Sundram’s expertise has been built-up through a sound publication record and collaborative research programs with American, Australian and European research centers. His work has won prestigious local and international awards including that of the Stanford University San Jose Tech Museum Intel Environment Award, the Geneva Inventions and Innovations Gold Award and seen successful product commercialization in the United States that resulted in the NASDAQ listing of Smart Balance Inc. based on his patented invention.
